Andembry
Andembry is an originator product from CSL Behring AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 16'158.45 to CHF 16'158.45 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- CSL Behring AG
- ATC code
- B06AC07
- IT group
- 02.99 Varia
- Active substances
- Garadacimabum
- Preparation type
- Originator product
- On the SL since
- 01/09/2025
- Last price change
- 01/09/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Lös 200 mg/1.2ml Fertpen | 1.2 ml | CHF 15'448.98 | CHF 16'158.45 | 01/09/2025 | B | 7680695530018 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
ANDEMBRY wird vergütet als Monotherapie zur Langzeitprophylaxe wiederkehrender akuter Schübe des hereditären Angioödems (HAE) vom Typ I oder Typ II bei Patienten ab einem Alter von 12 Jahren, die trotz on-demand Behandlung einen nachweislich schweren Verlauf UND ≥ 2 Attacken pro Monat über einen Zeitraum von 12 Monaten verzeichnen.
Die Einleitung und Überwachung der Behandlung erfolgt ausschliesslich über eines der folgenden Zentren: Universitätsspital Zürich, Inselspital Bern, Universitätsspital Basel, CHUV, HUG, Kantonsspi-tal Luzern, Kantonsspital Aarau und Kantonsspital St. Gallen, Hôpital du Valais (Institut Central des Hôpitaux (ICH) Sion und Ospedale Regionale di Bellinzona e Valli.
FAQ
Is Andembry covered by Swiss health insurance?
Yes, but only under conditions. Andembry is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Andembry cost in Switzerland?
The public price is the maximum price set by the FOPH and for Andembry ranges from CHF 16'158.45 to CHF 16'158.45 per pack. The ex-factory price ranges from CHF 15'448.98 to CHF 15'448.98. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages